CSL Ltd (CSL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:CSL Ltd (CSL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7401
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and secondary immune deficiencies, inherited respiratory disease and neurological disorders; influenza vaccine; and protein-based medicines for treating serious human illnesses. The company also provides products for the prevention of hemolytic disease in newborns and infection in solid organ transplant recipients and to treat specific infections and help victims of trauma, shock and burns. CSL also markets an array of vaccines, anti-venoms, and pharmaceutical products of various other manufacturers. The company sells its products in Australia, Germany, Switzerland, the UK, the US and rest of the world. CSL is headquartered in Parkville, Victoria, Australia.

CSL Ltd (CSL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CSL Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CSL Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CSL Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CSL Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
CSL Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CSL Ltd, Medical Equipment, Deal Details 10
Partnerships 10
CSL Behring Enters into Co-Development Agreement with Enable Injections 10
BioCSL Enters into Distribution Agreement with Immucor for Capture 11
Debt Offering 12
CSL Raises USD200 Million in Private Placement of 3.32% Debt Securities Due 2029 12
CSL Raises USD250 Million in Private Placement of 3.17% Debt Securities Due 2027 13
CSL Raises USD100 Million in Private Placement of 3.77% Debt Securities Due 2037 14
CSL Raises USD150 Million in Private Placement of 3.47% Debt Securities Due 2032 15
CSL Completes Private Placement Of Debt Securities Due 2020 For US$150 Million 16
CSL Completes Private Placement Of Debt Securities Due 2018 For US$100 Million 17
CSL Completes Private Placement Of Debt Securities Due 2023 For US$150 Million 18
CSL Completes Private Placement Of Debt Securities Due 2025 For US$100 Million 19
CSL Ltd – Key Competitors 20
CSL Ltd – Key Employees 21
CSL Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 25
Financial Announcements 25
Aug 15, 2018: CSL Delivers a Full Year Net Profit of $1.7 billion 25
Aug 16, 2017: CSL announces Full Year Result 2017 27
Feb 15, 2017: CSL Announces Half Year Result 2017 29
Jan 19, 2017: CSL reports FY2017 profit upgrade 31
Corporate Communications 32
Dec 13, 2017: CSL Appoints New Directors 32
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
CSL Ltd, Medical Equipment, Key Facts, 2018 2
CSL Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
CSL Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CSL Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
CSL Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CSL Ltd, Deals By Market, 2012 to YTD 2018 8
CSL Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
CSL Behring Enters into Co-Development Agreement with Enable Injections 10
BioCSL Enters into Distribution Agreement with Immucor for Capture 11
CSL Raises USD200 Million in Private Placement of 3.32% Debt Securities Due 2029 12
CSL Raises USD250 Million in Private Placement of 3.17% Debt Securities Due 2027 13
CSL Raises USD100 Million in Private Placement of 3.77% Debt Securities Due 2037 14
CSL Raises USD150 Million in Private Placement of 3.47% Debt Securities Due 2032 15
CSL Completes Private Placement Of Debt Securities Due 2020 For US$150 Million 16
CSL Completes Private Placement Of Debt Securities Due 2018 For US$100 Million 17
CSL Completes Private Placement Of Debt Securities Due 2023 For US$150 Million 18
CSL Completes Private Placement Of Debt Securities Due 2025 For US$100 Million 19
CSL Ltd, Key Competitors 20
CSL Ltd, Key Employees 21
CSL Ltd, Other Locations 22
CSL Ltd, Subsidiaries 22

List of Figures
CSL Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
CSL Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
CSL Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
CSL Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
CSL Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
CSL Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
CSL Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
CSL Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[CSL Ltd (CSL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Precision System Science Co Ltd (7707):企業の財務・戦略的SWOT分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company offers products such as automated nucleic acid isolation system, large sample volume nucleic acid extracti …
  • Tong Yang Life Insurance Co., Ltd.:企業の戦略・SWOT・財務分析
    Tong Yang Life Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tong Yang Life Insurance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Green Cross Cell Corp (031390)-製薬・医療分野:企業M&A・提携分析
    Summary Green Cross Cell Corp (Green Cross Cell), formerly Innocell Corp, a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offer …
  • eHealthInsurance Services Inc:企業の戦略的SWOT分析
    eHealthInsurance Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • MVV Energie AG:企業の戦略・SWOT・財務情報
    MVV Energie AG - Strategy, SWOT and Corporate Finance Report Summary MVV Energie AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Eris Lifesciences Ltd (ERIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Eris Lifesciences Ltd (Eris Lifesciences) is a health care products and service provider. The company offers glimepride, telmisertan, methylcobalamin and combinations, vitamin d, rabeprazole, olmesartan, mecobalamin colecalciferol, teneligliptin, rosa canina extract, cilnidipine, atorvastati …
  • L’Oreal SA:戦略・SWOT・企業財務分析
    L'Oreal SA - Strategy, SWOT and Corporate Finance Report Summary L'Oreal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lidco Group Plc (LID):企業の財務・戦略的SWOT分析
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic monitoring equipment. The company offers products such as LiDCOrapid, LiDCOunity, LiDCOplus, LiDCOview and LiDCOaccessories . Its LiDCOplus is a computer-based platform monitor, which is used in the intensive care …
  • Novolex Holdings, Inc.:企業の戦略的SWOT分析
    Novolex Holdings, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Escalon Medical Corp (ESMC):医療機器:M&Aディール及び事業提携情報
    Summary Escalon Medical Corp (Escalon) is a medical device company with primary focus on ophthalmology. It carries out the development and sale of ophthalmic medical devices. Its major products include A-Scan and B-Scan diagnostic tools, UBM high frequency/high resolution ultrasound devices, pachyme …
  • GUD Holdings Limited (GUD):企業の財務・戦略的SWOT分析
    GUD Holdings Limited (GUD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Scholastic Corporation:企業の戦略・SWOT・財務情報
    Scholastic Corporation - Strategy, SWOT and Corporate Finance Report Summary Scholastic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Havfisk ASA:企業の戦略・SWOT・財務分析
    Havfisk ASA - Strategy, SWOT and Corporate Finance Report Summary Havfisk ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Posco International Corp (047050):企業の財務・戦略的SWOT分析
    Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Crescendo Biologics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company s pipeline includes humabody programs targeting oncology. It specializes in the antibody discoveries and development that include CAT, …
  • FieldPoint Petroleum Corp (FPP):企業の財務・戦略的SWOT分析
    Summary FieldPoint Petroleum Corp (FieldPoint) is an oil and gas company that acquires, operates and develops oil and gas properties. The company’s acquisition includes leasehold and working interests in exploration areas. Its properties comprise South Vacuum field, Block A-49 and Block 6 field, Fly …
  • Bruce Power L.P.:企業の戦略的SWOT分析
    Bruce Power L.P. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Abreos Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • Eisai Co Ltd (4523):製薬・医療:M&Aディール及び事業提携情報
    Summary Eisai Co Ltd (Eisai) is a pharmaceutical company that undertakes the research, development, manufacture and marketing of pharmaceuticals, including over-the-counter (OTC) drugs, prescription medicines and generics. The company’s franchise areas in research include neurology and oncology. Eis …
  • Mercuria Energy Group Ltd:企業の戦略的SWOT分析
    Mercuria Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆